Latest Articles

All Latest Articles

150151 Articles

Paul Ausick | Mar 21, 2014 at 12:15 PM EDT

Biopharma Firm Versartis Gets Golden IPO Treatment

Biopharmaceutical firm Versartis sold 6 million shares in a Friday morning IPO at a price higher than the estimated range.…

Paul Ausick | Mar 21, 2014 at 11:35 AM EDT

Borderfree IPO Follows Lead of Other Recent Techs: Higher

Borderfree offered 5 million shares in an initial public offering Friday morning. Shares priced at the top of their expected…

Jon C. Ogg | Mar 21, 2014 at 11:20 AM EDT

Companies That Love March Madness the Most

ThinkstockMarch Madness has arrived for you college basketball fans. What is different about March Madness, versus the Daytona 500, the…

Paul Ausick | Mar 21, 2014 at 11:05 AM EDT

Amber Road IPO Races Off the Line

Amber Road, a maker of cloud-based software for global trade management, held its initial public offering (IPO) Friday, selling 7.4…

Douglas A. McIntyre | Mar 21, 2014 at 10:56 AM EDT

Ten American Cities With the Highest Unemployment

squirrel83, via Wikimedia CommonsThe Bureau of Labor Statistics has released its data on unemployment by city for January. In general,…

Jon C. Ogg | Mar 21, 2014 at 10:30 AM EDT

Did Endocyte Just Become Buyout Bait?

Endocyte is trading like it is being acquired. This is proof that any biotech with great cancer drug news can…

Paul Ausick | Mar 21, 2014 at 10:20 AM EDT

Nike: A Time to Buy?

Since being added to the Dow Jones Industrials Index last September, shares of Nike are up just over 11%. In…

Trey Thoelcke | Mar 21, 2014 at 10:05 AM EDT

Baird Very Cautious on Energy: Six Top Stocks to Buy Now

The Baird plan of action is pretty easy for investors to follow. Keep a smaller allocation of the energy sector,…

Jon C. Ogg | Mar 21, 2014 at 9:15 AM EDT

Merrill Lynch Defends Home Depot, Says It Is Headed to $100

Bank of America Merrill Lynch is defending Home Depot. What stands out here is not just that the firm is…

Paul Ausick | Mar 21, 2014 at 9:05 AM EDT

Could Obamacare Be Working?

WellPoint raised its earnings outlook for the 2014 fiscal year, citing a benefit from the Affordable Care Act, aka Obamacare,…

Jon C. Ogg | Mar 21, 2014 at 8:55 AM EDT

Herbalife Takes Key Independent Research Analyst Downgrade

Argus has downgraded Herbalife's near-term rating to Hold from Buy. The basis for the call is the recently announced Federal…

Trey Thoelcke | Mar 21, 2014 at 8:40 AM EDT

Credit Suisse’s Top Stocks to Buy for a Difficult 2014

After a huge run, it may be time to avoid momentum stocks and focus on quality names that will not…

Jon C. Ogg | Mar 21, 2014 at 8:25 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Boeing, Exelon, Herbalife, Symantec and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Friday, March 21, 2014.…

Jon C. Ogg | Mar 21, 2014 at 8:10 AM EDT

RBC’s Top Five North American Gold Stocks to Buy for 2014

This could be the moment the investors looking to own gold stocks have been waiting for. RBC Capital Markets analysts…

Paul Ausick | Mar 21, 2014 at 7:50 AM EDT

Google’s Delivery Service: Just Another Way to Use Search

Can the company that delivers search results in the digital world also deliver the goods in the brick-and-mortar world? And…

1 … 6,617 6,618 6,619 6,620 6,621 … 10,011

Latest Articles

All Latest Articles

Biopharma Firm Versartis Gets Golden IPO Treatment

Borderfree IPO Follows Lead of Other Recent Techs: Higher

Companies That Love March Madness the Most

Amber Road IPO Races Off the Line

Ten American Cities With the Highest Unemployment

Did Endocyte Just Become Buyout Bait?

Nike: A Time to Buy?

Baird Very Cautious on Energy: Six Top Stocks to Buy Now

Merrill Lynch Defends Home Depot, Says It Is Headed to $100

Could Obamacare Be Working?

Herbalife Takes Key Independent Research Analyst Downgrade

Credit Suisse’s Top Stocks to Buy for a Difficult 2014

Top Analyst Upgrades and Downgrades: Apple, Boeing, Exelon, Herbalife, Symantec and More

RBC’s Top Five North American Gold Stocks to Buy for 2014

Google’s Delivery Service: Just Another Way to Use Search

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

Latest Articles

All Latest Articles

Biopharma Firm Versartis Gets Golden IPO Treatment

Borderfree IPO Follows Lead of Other Recent Techs: Higher

Companies That Love March Madness the Most

Amber Road IPO Races Off the Line

Ten American Cities With the Highest Unemployment

Did Endocyte Just Become Buyout Bait?

Nike: A Time to Buy?

Baird Very Cautious on Energy: Six Top Stocks to Buy Now

Merrill Lynch Defends Home Depot, Says It Is Headed to $100

Could Obamacare Be Working?

Herbalife Takes Key Independent Research Analyst Downgrade

Credit Suisse’s Top Stocks to Buy for a Difficult 2014

Top Analyst Upgrades and Downgrades: Apple, Boeing, Exelon, Herbalife, Symantec and More

RBC’s Top Five North American Gold Stocks to Buy for 2014

Google’s Delivery Service: Just Another Way to Use Search

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

Featured Reads

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.